Translational Research in ROS1-Positive NSCLC: Are We Moving Out of the Six Blind Men and the Elephant Stage?

Lee, Jii Bum; Nagasaka, Misako

Lee, Jii Bum; Nagasaka, Misako.

Affiliation

Lee JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: joy88lee@yuhs.ac.
Nagasaka M; Division of Hematology-Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California; Chao Family Comprehensive Cancer Center, Orange, California.

J Thorac Oncol ; 19(4): 525-527, 2024 Apr.

Article in En | MEDLINE | ID: mdl-38582542

Subject(s)

Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Humans; Protein-Tyrosine Kinases/genetics; Lung Neoplasms/genetics; Translational Research, Biomedical; Proto-Oncogene Proteins; Carcinoma, Non-Small-Cell Lung/genetics; Protein Kinase Inhibitors

Key words

Crizotinib; NSCLC; ROS1 fusion; Variants

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2024 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google